Experimental models in asthma

Clinical and Experimental Allergy, Supplement

Volumn 29, Issue 3, 1999, Pages 82-86

  Holgate, S T ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Allergen; Basophils; Exercise; Hypertonic stimuli; Inhaled adenosine

Indexed keywords

ADENOSINE; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ALLERGIC ASTHMA; ALLERGIC REACTION; ARTICLE; ASTHMA; BASOPHIL DEGRANULATION; BRONCHOSPASM; EXERCISE INDUCED ASTHMA; HISTAMINE RELEASE; HUMAN; MAST CELL DEGRANULATION; MEDIATOR; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0032784836     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.0290s3082.x     Document Type: Article

References (53)

1. Dale HH, Laidlaw PP. The physiological action of β-iminazoly-ethylamine. J Physiol 1910; 41:318-41.
2. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988; 137:62-9.
3. Holgate ST, Finnerty JP. Antihistamines in asthma. J Allergy Clin Immunol 1989; 83:537-47.
4. Redington AE, Polosa R, Walls AF, Howarth PH, Holgate ST. Role of mast cels and basophils in asthma. In: Marone G, ed. Human Basophils and Mast Cells Clinical Aspects, Vol. 62, pp. 22-59.
5. Djukanovíc R, Wilson JW, Britten KM, et al. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 1990; 142:863-71.
6. Galli SJ, Wershil BK. The two faces of the mast cell. Nature 1996; 381:21-2.
7. εR1 expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 1997; 186:672-703.
8. Liu MC, Hubbard WC, Proud D, et al. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Am Rev Respir Dis 1991; 144:51-8.
9. Wenzel SE, Fowler AA III, Schwartz LB. Activation of pulmonary mast cells by bronchoalveolar allergen challenge: in vivo release of histamine and tryptase in atopic subjects with and without asthma. Am Rev Respir Dis 1988; 137:1002-8.
10. 2 and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am Rev Respir Dis 1990; 142:126-32.
11. Liu MC, Calhoun WJ. Bronchoalveolar lavage studies in asthma. In: Holgate ST, Bussee WW, ed. Inflammatory Mechanisms in Asthma, New York: Marcel Dekker, 1998: pp. 39-74.
12. Broide DH, Gleich GJ, Cuomo AJ, et al. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthmatic airways. J Allergy Clin Immunol 1991; 88:637-48.
13. Bradding P, Roberts JA, Britten KM, et al. Interleukin-4, -5, -6 and TNFα in normal and asthmatic airways: evidence for the human mast cell as an important source of these cytokines. Am J Respir Cell Mol Biol 1994; 10:471-80.
14. Bradding P, Okayama Y, Church MK, Holgate ST. Heterogeneity of human mast cells based on their cytokine content. J Immunol 1995; 155:297-307.
15. Okayama Y, Petit-Frére C, Kassel O, et al. Expression of messenger RNA for IL-4 and IL-5 in human lung and skin mast cells in response to FCε receptor cross-linkage and the presence of stem cell factor. J Immunol 1995; 155:1796-808.
16. Wenzel SE, Westcott JY, Larsen GL. Bronchoalveolar lavage mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: relationship to the development of the late asthmatic response. J Allergy Clin Immunol 1991; 87:540-8.
17. Howarth PH, Durham SR, Lee TH, Kay AB, Church MK, Holgate ST. Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to antigen bronchial provocation in asthma. Am Rev Respir Dis 1985; 132:986-92.
18. Dahlén S-E, Kumlin M. Can asthma be studied in the urine? Clin Exp Allergy 1998; 28:129-33.
19. 1-antihistamine, on the early and late allergic reactions in a bronchial provocation test with allergen. J Allergy Clin Immunol 1993; 91:1189-97.
20. Holgate ST, Finnerty JP. Antihistamines in asthma. J Allergy Clin Immunol 1989; 83 (Suppl.):537-47.
21. 1-receptor antagonism. Clin Exp Allergy 1990; 20 (Suppl.2):31-41.
22. Beasley CRW, Featherstone RL, Church MK, et al. The effect of the thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction. J Appl Physiol 1989; 66:1685-93.
23. 4 and histamine in asthmatics. Am Rev Respir Dis 1992; 146:96-103.
24. Redier H, Chanez P, De Vos C et al. Inhibitory effect cetirizine bronchila eosinophil recruitment induced allergen inhalation challenge allergic patients with asthma. J Allergy Clin Immunol 1992; 90:215-24.
25. Hamid M, Rafferty P, Holgate ST. The inhibitory effect of terfenadine and flurbiprofen on early and late phase bronchoconstriction following allergen challenge in atopic asthma. Clin Exp Allergy 1990; 20:261-6.
26. Town GI, Holgate ST. Comparison of the effect of loratidine on the airway and skin responses to histamine, methacholine and allergen in asthmatic subjects. J Allergy Clin Immunol 1990; 86:806-93.
27. Guo C, Liu M, Galli S, et al. Identification of IgE-bearing cells in the late phase response to antigen in the lung as basophils. Am J Resp Cell Mol Biol 1994; 10:384-90.
28. Taylor IK, O'Shaughnessy KM, Fuller RW, et al. Effect of the cysteinyl-leukotriene receptor antagonist ICI 204,219 on allergen-induced bronchoconstrictiosn and airway hyperreactivity in atopic subjects. Lancet 1991; 337:690-4.
29. Kepley CL, Craig SS, Schwartz LB. Identification and partial characterization of a unique marker for human basophils. J Immunol 1995; 154: 6548-55.
30. McEuen AR, Buckley MG, Compton SJ, Walls AF. Development and characterization of a monoclonal antibody specific for human basophils and the identification of a unique secretory product of basophil activation. Lab Invest 1999; 79: 27-38.
31. Anderson SD, Daviskas E, Smith CM. Exercise-induced asthma: a difference in opinion regarding the stimulus. Allergy Proc 1989; 10:215-26.
32. Jarjour NN, Calhoun WJ. Exercise-induced asthma is not associated with mast cell activation or airway inflammation. J Allergy Clin Immunol 1992; 89:60-8.
33. 4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 1997; 52:1030-5.
34. Patel KR. Terfenadine in exercise-induced asthma. Br Med J 1984; 288: 1496-7.
35. Rafferty P, Ng WH, Phillips GD et al. The inhibitory actions of azelastine hydrochloride on the early and late bronchoconstrictor response to inhaled allergen in atopic asthma. J Allergy Clin Immunol 1989; 84: 649-57.
36. 4-receptor antagonist. Am Rev Respir Dis 1992; 145:746-9.
37. 4-receptor antagonist. N Engl J Med 1990; 323:1736-9.
38. Makker HK, Holgate ST. Mechanisms of exercise-induced asthma. Eur J Clin Invest 1994; 24:571-85.
39. Togias AG, Proud D, Lichtenstein LM et al. The osmalarity of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air. Am Rev Respir Dis 1988; 137:625-9.
40. Makker HK, Holgate ST. Relation of the hypertonic saline responsiveness of the airways to exercise induced asthma symptom severity and to histamine or methacholine reactivity. Thorax 1993; 48:142-7.
41. Cushley MJ, Tattersfield AE, Holgate ST. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol 1983; 15:161-5.
42. Polosa R, Holgate ST. Adenosine bronchoprovocation: a promising marker of allergic inflammation in asthma? Thorax 1997; 52:919-23.
43. 2B receptors: a novel therapeutic target in asthma? Trends Pharmacol Sci 1998; 19:148-53.
44. Phillips GD, Ng R, Church MK, Holgate ST. The response of plasma histamine to bronchoprovocation with methacholine, adenosine 5′-monophosphate, and allergen in atopic non-asthmatic subjects. Am Rev Respir Dis 1990; 141:9-13.
45. Polosa R, Ng WH, Crimi N, et al. Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma. Am J Resp Crit Care Med 1995; 151:624-9.
46. Rafferty P, Beasley CR, Holgate ST. The contribution of histamine to bronchoconstriction produced by inhaled allergen and adenosine 5′-monophosphate in asthma. Am Rev Respir Dis 1987; 136:369-73.
47. O'Connor BJ, Aikman S, Barnes PJ. Tolerance to the non-bronchodilator effects of inhaled beta-agonists in asthma. N Engl J Med 1992; 327:1204-8.
48. Wilson SJ, Djukanovíc R, Holgate S, Kraft M, Martin R. Evidence for enhanced IL-4 and IL-5 secretion in the peripheral but not the conducting airways in nocturnal asthma. Am J Respir Crit Care Med 1996; 153:A879.
49. Barnes NC, Fabbri L. Treatment of asthma with anti-leukotrienes: current and future trends. In: Holgate ST, Dahlén S-E, ed. SRS-a to Leukotrienes: the Dawning of a New Treatment, Oxford: Blackwell Science 1997: pp. 321-6.
50. Kubes P. Mast cell activation and leukocyte rolling responses. In: Bochner BS, ed. Adhesion Molecules in: Allergic Disease. Marcel Dekker, NY, 1997: pp. 229-6.
51. Montefort S, Gratziou C, Goulding D, et al. Bronchial biopsy evidence for leucocyte infiltration and upregulation of leucocyte endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitised asthmatic airway. J Clin Invest 1994; 93:1411-21.
52. Roquet A, Dahlén B, Kumlin M, et al. Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Am J Respir Crit Care Med 1997; 155:1856-63.
53. Van Ganse E, Kaufman L, Derde MP, et al. Effects of antihistamines in adult asthma: a meta-analysis of clinical trials. Eur Respir J 1997; 10:2216-24.